EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

How does the clinical and tomographic appearance of MRONJ influences its treatment prognosis?

Catalina Moreno Rabie iD, Santiago García-Larraín, David Contreras Diez de Medina, Isadora Cabello-Salazar, Rocharles Cavalcante Fontenele, Tim Van den Wyngaert, Reinhilde Jacobs iD

Dentomaxillofacial Radiology · 2023

DOI: 10.1259/dmfr.20230304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dentomaxillofacial Radiology, 2023. Verfasst von Catalina Moreno Rabie und 6 weiteren Autor:innen. Beteiligte Einrichtung: OMFS-IMPATH Research Group, Department of Imaging and Pathology, Faculty of Medicine, University of Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Density Conservation Agents, Osteosclerosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To identify clinical and tomographic prognostic factors for conservative and surgical treatment of medication-related osteonecrosis of the jaws (MRONJ).

Methods

A retrospective search identified patients treated with antiresorptive drugs (ARDs), diagnosed with Stage 1, 2 or 3 MRONJ, and having CBCT scans previous to conservative or surgical treatment. Following data collection, imaging assessment of the following parameters on each MRONJ site was performed: involvement of teeth and/or implants, presence of osteosclerosis, osteolysis, sequestrum formation, periosteal reaction, and pathological fractures. For statistical analysis, patients and lesions were divided into conservative and surgical treatment. Comparisons were made between successful and unsuccessful outcomes. Significance was set at p ≤ 0.05.

Results

115 ARD-treated patients who developed 143 osteonecrosis lesions were selected. 40 patients and 58 lesions received conservative treatment, of which 14 patients (35%) and 25 lesions (43%) healed. Additionally, 75 patients and 85 lesions underwent surgery, with 48 patients (64%) and 55 lesions (65%) that healed. Clinical and tomographic risk factors for conservative treatment were MRONJ staging, tooth involvement, extensive osteosclerosis, and deep sequestrum formation (p < 0.05). Complementarily, poor prognostic indicators for surgical therapy were a short bisphosphonate (BP) holiday, MRONJ staging, absence of sequestrum formation, and presence of periosteal reaction (p < 0.05).

Conclusions

Lesions at Stage 3 MRONJ, with tooth involvement, or sequestrum formation showed poor outcomes when conservative treatment is chosen. Alternatively, surgical treatment is most effective when BPs are discontinued, in Stage 1 lesions, in the presence of sequestrum formation, and absence of periosteal reaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsOsteosclerosisHumansRetrospective StudiesPrognosis

Stichwörter der Autor:innen

cone-beam computed tomographydiagnostic imagingosteonecrosisprognosistherapy

Substanzen

Bone Density Conservation Agents

Autor:innen und Institutionen

  • OMFS-IMPATH Research Group, Department of Imaging and Pathology, Faculty of Medicine, University of Leuven, Leuven, Belgium.
  • Department of Oral and Maxillofacial Surgery, University Hospitals Leuven, Leuven, Belgium.
  • Department of Oral and Maxillofacial Radiology, Facultad de Odontología, Universidad de los Andes, Santiago, Chile.
  • Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium.
  • Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Catalina Moreno Rabie, Reinhilde Jacobs

Zitieren

APA

Moreno Rabie, C., García-Larraín, S., Contreras Diez de Medina, D., Cabello-Salazar, I., Fontenele, R. C., Van den Wyngaert, T., & Jacobs, R. (2023). How does the clinical and tomographic appearance of MRONJ influences its treatment prognosis?. Dentomaxillofacial Radiology. https://doi.org/10.1259/dmfr.20230304

Vancouver

Moreno Rabie C, García-Larraín S, Contreras Diez de Medina D, Cabello-Salazar I, Fontenele RC, Van den Wyngaert T, et al. How does the clinical and tomographic appearance of MRONJ influences its treatment prognosis?. Dentomaxillofacial Radiology. 2023. doi:10.1259/dmfr.20230304

BibTeX
@article{MorenoRabie2023,
  author = {Moreno Rabie, Catalina and García-Larraín, Santiago and Contreras Diez de Medina, David and Cabello-Salazar, Isadora and Fontenele, Rocharles Cavalcante and Van den Wyngaert, Tim and Jacobs, Reinhilde},
  title = {How does the clinical and tomographic appearance of MRONJ influences its treatment prognosis?},
  journal = {Dentomaxillofacial Radiology},
  year = {2023},
  doi = {10.1259/dmfr.20230304}
}
Kostenlos starten →